Effect of anticoagulant choice on apparent antioxidant capacity
We read with interest the report of Goode et al.
describing the effect of anticoagulant choice on apparent total antioxidant capacity.' They show that antioxidant capacity is increased when blood is collected using heparin as an anticoagulant, and suggest that heparin might enhance anticoagulant protection via release of endothelial superoxide dismutase. It is certainly possible that this mechanism might contribute to increased antioxidant capacity in plasma when heparin is administered to a patient, but it is difficult to see how it is relevant when a blood sample is placed in a heparinized tube after collection.
As suggested by Goode et al., several rapid and simple assays are now available to measure total antioxidant capacity. In view of current growing interest in the role of free radical production and antioxidant depletion in a wide range of diseases such assays have a number of attractions. They require a small sample volume (making them particularly suitable for paediatric workj-and they take into account the complex interactions which occur between chain-breaking antioxidants. In addition, they provide a measure of the contribution of chain-breaking antioxidants which are not otherwise easily measured, such as the flavonoids and ubiquinol. However, while recognizing the usefulness of such properties, we believe that it is important to remember the limitations of these assays. The relative importance of antioxidants varies widely depending on the oxidizing process.'
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Assays for total antioxidant capacity such as those described by Whitehead" and Miller 2 are dominated by the effects of urate and thiol groups when applied to plasma. Each of these may have an important role as an antioxidant in response to some forms of oxidative stress, but other antioxidants (such as ascorbate and tocopherol) are likely to be more important in many biological settings. These antioxidants make only a small contribution to total antioxidant capacity in the assays used in this paper. Thus, a relatively normal or even increased total antioxidant capacity as measured by one of these assays might mask a significant depletion of a key antioxidant such as ascorbate or tocopherol, and hence provide misleading reassurance about an individual's antioxidant status. This situation could arise, for instance, in haemodialysis patients, where urate tends to be increased.! We would therefore like to suggest that when total antioxidant capacity of plasma is assessed, it is important to individually measure in addition the major chain-breaking antioxidants (ascorbate, tocopherol, urate, thiols and bilirubin) if a potentially misleading impression of antioxidant status is to be avoided. 
